Medgroup Inc.
Other OTCTotal Valuation
Medgroup Inc. carries a market capitalization of 1.45M, placing it among publicly traded companies globally. Its enterprise value stands at 1.76M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.45M |
| Enterprise Value | 1.76M |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | 0.45 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 0.45 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 0.26 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.45 |
| EV / EBITDA | 0.26 |
| EV / EBIT | 0.26 |
| EV / FCF | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -97.78 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Income Statement
Over the trailing twelve months, Medgroup Inc. generated 3.90M in revenue and converted that into -2.20M in net income, yielding earnings per share of -0.14. EBITDA reached 6.70M, while operating income came in at 6.70M.
| Revenue | 3.90M |
| Gross Profit | N/A |
| Operating Income | 6.70M |
| Pretax Income | N/A |
| Net Income | -2.20M |
| EBITDA | 6.70M |
| EBIT | 6.70M |
| Earnings Per Share (EPS) | -0.14 |
Margins
Medgroup Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of 171.79 and net profit margin of -56.41 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | 171.79 |
| Pretax Margin | N/A |
| Profit Margin | -56.41 |
| EBITDA Margin | 171.79 |
Stock Splits
Medgroup Inc.'s most recent stock split took place on January 11, 1993 with a 4:5 split ratio.
| Last Split Date | 1/11/1993 |
| Split Ratio | 4:5 |